Glucosio Con Sodio Cloruro Ii Bioindustria L.I.M.

Glucosio Con Sodio Cloruro Ii Bioindustria L.I.M. is a sterile intravenous solution that combines sodium chloride and glucose monohydrate. The product is supplied as a solution for injection, with strength not specified in the public data. It is classified as an IV electrolyte solution used for fluid and electrolyte replacement. The preparation is marketed in the European Union and requires a prescription for clinical use.

Glucosio Con Sodio Cloruro Ii Bioindustria is indicated for several clinical situations that require rapid restoration of intravascular volume and energy substrates.

- Rehydration and fluid replacement in patients with dehydration or blood loss. - Electrolyte replenishment, particularly sodium, in postoperative or critically ill patients. - Treatment of hypoglycemia when an immediate glucose source is needed. - Support during surgery or invasive procedures to maintain hemodynamic stability. - Adjunct therapy for metabolic disorders that impair glucose utilization.

The safety profile of the sodium chloride and glucose injection reflects the expected effects of its components when administered intravenously.

Common: - Mild irritation or pain at the injection site. - Transient increase in blood glucose levels. - Slight electrolyte imbalance such as hypernatremia if administered in excess. - Temporary feeling of warmth or flushing.

Serious: - Severe hypernatremia leading to neurological symptoms. - Hypersensitivity reactions including rash, itching, or anaphylaxis. - Fluid overload causing pulmonary edema or heart failure.

When using Glucosio Con Sodio Cloruro Ii Bioindustria, clinicians should consider several precautionary measures to minimize risks.

- Assess baseline electrolyte status and blood glucose before infusion. - Adjust infusion rate in patients with renal or cardiac insufficiency. - Avoid rapid large-volume administration in children or the elderly. - Monitor for signs of fluid overload, especially in patients with congestive heart failure. - Use aseptic technique to prevent contamination of the sterile solution. - Discontinue if an allergic reaction or severe hypernatremia develops. - Document dosage and infusion parameters in the patient record.

The intravenous solution may interact with other medications or clinical conditions; awareness of these interactions helps ensure safe use.

Avoid: - Concurrent administration of hypertonic saline solutions, which can exacerbate hypernatremia. - High-dose insulin therapy without glucose supplementation, increasing risk of hypoglycemia. - Diuretics that may cause rapid electrolyte shifts when combined with large-volume infusions.

Use with caution: - Medications that affect renal function, such as aminoglycosides or NSAIDs. - Cardiovascular drugs that influence fluid balance, including ACE inhibitors or beta‑blockers. - Blood products or total parenteral nutrition formulas that contain sodium or glucose.